You can:
Name | Histamine H3 receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | HRH3 |
Synonym | HH3R H3R H3 receptor GPCR97 G-protein coupled receptor 97 |
Disease | Obese insulin-resistant disorders Excessive daytime sleepiness Sleep disorders Schizophrenia Pain [ Show all ] |
Length | 445 |
Amino acid sequence | MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK |
UniProt | Q9Y5N1 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q9Y5N1 |
3D structure model | This predicted structure model is from GPCR-EXP Q9Y5N1. |
BioLiP | N/A |
Therapeutic Target Database | T64765 |
ChEMBL | CHEMBL264 |
IUPHAR | 264 |
DrugBank | BE0000968 |
Name | histamine |
---|---|
Molecular formula | C5H9N3 |
IUPAC name | 2-(1H-imidazol-5-yl)ethanamine |
Molecular weight | 111.148 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 2 |
XlogP | -0.7 |
Synonyms | NCGC00093371-05 Racemic histamine Histamine, base, >=97.0% (NT) SMR000059091 HMS1792G19 [ Show all ] |
Inchi Key | NTYJJOPFIAHURM-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8) |
PubChem CID | 774 |
ChEMBL | CHEMBL90 |
IUPHAR | 1247, 1204 |
BindingDB | 7966, 50121205 |
DrugBank | DB05381 |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
Activity | 110.0 % | PMID20384344 | ChEMBL |
EC50 | 4.074 nM | PMID12825954 | ChEMBL |
EC50 | 5.012 nM | PMID21044842 | ChEMBL |
EC50 | 9.772 nM | PMID14640553 | ChEMBL |
EC50 | 12.88 nM | MedChemComm, (2014) 5:1:72, PMID20409707 | BindingDB,ChEMBL |
EC50 | 13.0 nM | PMID27007611 | BindingDB,ChEMBL |
EC50 | 15.85 nM | PMID21348462 | BindingDB,ChEMBL |
EC50 | 25.0 nM | PMID19317445 | BindingDB |
EC50 | 25.1 nM | PMID18950149 | BindingDB,ChEMBL |
EC50 | 25.12 nM | PMID19317445, MedChemComm, (2014) 5:1:72, PMID19791743 | BindingDB,ChEMBL |
EC50 | 77.0 nM | PMID12723960 | BindingDB,ChEMBL |
EC50 | 88.0 nM | PMID16942032 | BindingDB,ChEMBL |
EC50 | 640.0 nM | PMID20384344 | BindingDB,ChEMBL |
Efficacy | 1.0 - | PMID12825954 | ChEMBL |
Emax | 1.0 % | PMID20409707 | ChEMBL |
Intrinsic activity | 1.0 - | PMID21044842, PMID14640553 | ChEMBL |
Kd | 10.0 nM | PMID11179434, PMID11179435 | IUPHAR |
Ki | <10000.0 nM | PMID10347254 | PDSP,BindingDB |
Ki | 2.32 nM | PMID15033391 | PDSP,BindingDB |
Ki | 2.61 nM | PMID15033391 | BindingDB |
Ki | 3.0 nM | PMID11179436 | PDSP |
Ki | 5.01187 - 15.8489 nM | PMID10869375, PMID11284713, PMID11090094, PMID12393057, PMID11179434, PMID14640553 | IUPHAR |
Ki | 5.2 nM | PMID20384344 | BindingDB,ChEMBL |
Ki | 5.2 nM | PMID20384344 | PDSP |
Ki | 5.4 nM | PMID11179434 | PDSP,BindingDB |
Ki | 6.31 nM | PMID22003888 | BindingDB,ChEMBL |
Ki | 9.333 nM | PMID14640553 | ChEMBL |
Ki | 10.0 nM | PMID21044842, PMID15947036 | BindingDB,ChEMBL |
Ki | 11.75 nM | PMID21348462 | BindingDB,ChEMBL |
Ki | 12.8 nM | PMID27692832 | ChEMBL |
Ki | 13.0 nM | PMID27692832 | BindingDB |
Ki | 15.2 nM | PMID10869375 | PDSP,BindingDB |
Ki | 16.0 nM | PMID25993395 | BindingDB,ChEMBL |
Ki | 33.88 nM | PMID12825954 | ChEMBL |
Selectivity | 1.6 - | PMID14640553 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417